Picterus AS
14
3
3
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
2 terminated/withdrawn out of 14 trials
77.8%
-8.7% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)
Role: lead
Screening for Neonatal Jaundice With a Mobile Health Device: a Validation Study in Oaxaca, Mexico.
Role: collaborator
mHealth to Screen for Neonatal Jaundice in Low-resource Mexican Settings: a Feasibility Study
Role: collaborator
Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana
Role: collaborator
Evaluation of Bilirubin Measurements in Newborns From Smartphone Digital Images in a Population in Botswana
Role: lead
Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population
Role: lead
Evaluation of a Smartphone Based Screening Tool for Neonatal Jaundice in Surabaya, Indonesia
Role: lead
Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro
Role: lead
Clinical Validation of the Screening Tool Picterus JP Using Different Smartphones
Role: lead
Validation of an Innovative Neonatal Jaundice Detection System (Picterus) in Indonesia
Role: lead
Evaluation of a Smartphone-based Screening Tool (Picterus Jaundice Pro) for Neonatal Jaundice in Dark Skin Newborns
Role: lead
Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Nepali Population
Role: lead
A mHealth Application as a Screening Tool for Neonatal Jaundice in Filipino Neonates
Role: lead
Evaluation of a Smartphone Based Diagnostic Tool to Assess Neonatal Jaundice in a Mexican Population
Role: lead
All 14 trials loaded